Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 8 April 1988:
Vol. 240. no. 4849, pp. 196 - 199
DOI: 10.1126/science.2895499

Articles

Science, Vol 240, Issue 4849, 196-199
Copyright © 1988 by American Association for the Advancement of Science


articles

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells

A Kimchi, XF Wang, RA Weinberg, S Cheifetz, and J Massague

Department of Virology, Weizmann Institute of Science, Rehovot, Israel.

The responses of retinoblastoma tumor cells and normal retinal cells to various growth inhibitory factors were examined. Whereas fetal retinal cells were highly sensitive to the antimitogenic effects of transforming growth factor beta 1 (TGF-beta 1), retinoblastoma tumor cell lines were all resistant to this factor. Binding assays and affinity labeling of these cells with radioiodinated TGF-beta 1 revealed that the cells did not have TGF-beta receptors. The retinoblastoma cells lacked the three affinity-labeled proteins of 65, 95, and 300 kilodaltons typically seen in human cell lines and thus differed from normal retinal cells and from other types of neuroectodermal tumors that display the normal pattern of receptors. Loss of TGF-beta receptors, which is a rare event among tumor cells, may represent one mechanism through which these cells escape from negative control and form retinoblastomas.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
SMAD6 Contributes to Patient Survival in Non-Small Cell Lung Cancer and Its Knockdown Reestablishes TGF-{beta} Homeostasis in Lung Cancer Cells.
H.-S. Jeon, T. Dracheva, S.-H. Yang, D. Meerzaman, J. Fukuoka, A. Shakoori, K. Shilo, W. D. Travis, and J. Jen (2008)
Cancer Res. 68, 9686-9692
   Abstract »    Full Text »    PDF »
Transforming growth factor-{beta} signaling and ubiquitinators in cancer.
E. Glasgow and L. Mishra (2008)
Endocr. Relat. Cancer 15, 59-72
   Abstract »    Full Text »    PDF »
Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis.
P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress (2004)
Cancer Res. 64, 6524-6529
   Abstract »    Full Text »    PDF »
PMEPA1, a Transforming Growth Factor-{beta}-induced Marker of Terminal Colonocyte Differentiation Whose Expression Is Maintained in Primary and Metastatic Colon Cancer.
E. B. Brunschwig, K. Wilson, D. Mack, D. Dawson, E. Lawrence, J. K.V. Willson, S. Lu, A. Nosrati, R. M. Rerko, S. Swinler, et al. (2003)
Cancer Res. 63, 1568-1575
   Abstract »    Full Text »    PDF »
Disruption of Transforming Growth Factor {beta} Signaling by a Novel Ligand-dependent Mechanism.
T. Fernandez, S. Amoroso, S. Sharpe, G. M. Jones, V. Bliskovski, A. Kovalchuk, L. M. Wakefield, S.-J. Kim, M. Potter, and J. J. Letterio (2002)
J. Exp. Med. 195, 1247-1255
   Abstract »    Full Text »    PDF »
Vascular Endothelial Cell Growth Factors Promote the In Vitro Development of Rat Photoreceptor Cells.
P. A. Yourey, S. Gohari, J. L. Su, and R. F. Alderson (2000)
J. Neurosci. 20, 6781-6788
   Abstract »    Full Text »    PDF »
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis.
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld (2000)
Blood 96, 2022-2036
   Abstract »    Full Text »    PDF »
Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell-Surface TGF-{beta} Type II Receptor in a Short-Term In Vitro Assay.
N. Fortunel, J. Hatzfeld, S. Kisselev, M.-N. Monier, K. Ducos, A. Cardoso, P. Batard, and A. Hatzfeld (2000)
Stem Cells 18, 102-111
   Abstract »    Full Text »
A Deletion in the Gene for Transforming Growth Factor beta Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor beta in a Cutaneous T-Cell Lymphoma.
W. P. Schiemann, W. M. Pfeifer, E. Levi, M. E. Kadin, and H. F. Lodish (1999)
Blood 94, 2854-2861
   Abstract »    Full Text »    PDF »
p53-Independent Role of MDM2 in TGF-1 Resistance.
P. Sun, P. Dong, K. Dai, G. J. Hannon, and D. Beach (1998)
Science 282, 2270-2272
   Abstract »    Full Text »
High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells.
N Fortunel, P Batard, A Hatzfeld, M. Monier, B Panterne, J Lebkowski, and J Hatzfeld (1998)
J. Cell Sci. 111, 1867-1875
   Abstract »    PDF »
Consistent loss of functional transforming growth factor beta  receptor expression in murine plasmacytomas.
S. R. Amoroso, N. Huang, A. B. Roberts, M. Potter, and J. J. Letterio (1998)
PNAS 95, 189-194
   Abstract »    Full Text »    PDF »
Expression of Transforming Growth Factor beta  Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells.
L. Sun and C. Chen (1997)
J. Biol. Chem. 272, 25367-25372
   Abstract »    Full Text »    PDF »
Loss of functional cell surface transforming growth factor beta  (TGF-beta ) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
J. F. DeCoteau, P. I. Knaus, H. Yankelev, M. D. Reis, R. Lowsky, H. F. Lodish, and M. E. Kadin (1997)
PNAS 94, 5877-5881
   Abstract »    Full Text »    PDF »
Expression of Transforming Growth Factor beta  (TGFbeta ) Type III Receptor Restores Autocrine TGFbeta 1 Activity in Human Breast Cancer MCF-7 Cells.
C. Chen, X.-F. Wang, and L. Sun (1997)
J. Biol. Chem. 272, 12862-12867
   Abstract »    Full Text »    PDF »
The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line.
A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin (1997)
Endocrinology 138, 1498-1505
   Abstract »    Full Text »    PDF »
Mechanism of E1A-Induced Transforming Growth Factor-beta (TGF-beta ) Resistance in Mouse Keratinocytes Involves Repression of TGF-beta Type II Receptor Transcription.
D. H. Kim, J. H. Chang, K. H. Lee, H.-Y. Lee, and S.-J. Kim (1997)
J. Biol. Chem. 272, 688-694
   Abstract »    Full Text »    PDF »
Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells.
J. Wang, W. Han, E. Zborowska, J. Liang, X. Wang, J. K.V. Willson, L. Sun, and M. G. Brattain (1996)
J. Biol. Chem. 271, 17366-17371
   Abstract »    Full Text »    PDF »
Characterization of the Promoter Region of the Human Transforming Growth Factor-beta Type II Receptor Gene.
H. W. Bae, A. G. Geiser, D. H. Kim, M. T. Chung, J. K. Burmester, M. B. Sporn, A. B. Roberts, and S.-J. Kim (1995)
J. Biol. Chem. 270, 29460-29468
   Abstract »    Full Text »    PDF »
Demonstration That Mutation of the Type II Transforming Growth Factor beta Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells.
J. Wang, L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. V. Willson, et al. (1995)
J. Biol. Chem. 270, 22044-22049
   Abstract »    Full Text »    PDF »
Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-beta Receptors.
M. E. Choi and B. J. Ballermann (1995)
J. Biol. Chem. 270, 21144-21150
   Abstract »    Full Text »    PDF »
Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription.
T. Brand and M. D. Schneider (1995)
J. Biol. Chem. 270, 8274-8284
   Abstract »    Full Text »    PDF »
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
R. Chen, R Ebner, and R Derynck (1993)
Science 260, 1335-1338
   Abstract »    PDF »
c-myc and pRB: Role in TGF-{beta}1 Inhibition of Keratinocyte Proliferation.
C.S. Murphy, J.A. Pietenpol, K. Munger, P.M. Howley, and H.L. Moses (1991)
Cold Spring Harb Symp Quant Biol 56, 129-135
   Abstract »    PDF »
Anti-oncogenes and the Negative Regulation of Cell Growth.
J.M. Horowitz, S.H. Friend, R.A. Weinberg, P. Whyte, K. Buchkovich, and E. Harlow (1988)
Cold Spring Harb Symp Quant Biol 53, 843-847
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)